Long non-coding RNA polymorphisms and prediction of response to chemotherapy based on irinotecan in patients with metastatic colorectal cancer-Reference-Cited by-同舟云学术

Long non-coding RNA polymorphisms and prediction of response to chemotherapy based on irinotecan in patients with metastatic colorectal cancer

Published:2019-06-10 Issue:2 Volume:25 Page:213-221
ISSN:1875-8592
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Lampropoulou Dimitra-Ioanna¹,Aravantinos Gerasimos¹,Katifelis Hector²,Lazaris Foivos²,Laschos Konstantinos¹,Theodosopoulos Theodosios³,Papadimitriou Christos³,Gazouli Maria²

Affiliation:

1. Second Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece

2. Laboratory of Biology, Medical School, National and Kapodistrian University of Athens, Athens, Greece

3. Second Department of Surgery, Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference57 articles.

1. Worldwide burden of colorectal cancer: a review;Favoriti;Updates in Surgery,2016

2. Pharmacologic resistance in colorectal cancer: A review;Hammond;Therapeutic Advances in Medical Oncology,2016

3. Prediction of response to irinotecan and drug toxicity based on pharmacogenomics test: A prospective case study in advanced colorectal cancer;Emani;Asian Pacific Journal of Cancer Prevention,2017

4. miRNAs and lncRNAs as predictive biomarkers of response to FOLFOX therapy in colorectal cancer;Hon;Frontiers in Pharmacology,2018

5. Long non-coding RNAs and drug resistance;Pan;Asian Pacific Journal of Cancer Prevention,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the ncRNA landscape that governs colorectal cancer: A roadmap to personalized therapeutics;Life Sciences;2024-10

2. Key Non-coding Variants in Three Neuroapoptosis and Neuroinflammation-Related LncRNAs Are Protectively Associated with Susceptibility to Parkinson’s Disease and Some of Its Clinical Features;Molecular Neurobiology;2023-11-09

3. Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors;Annals of Medicine;2023-04-24

4. MALAT1 in colorectal cancer: Its implication as a diagnostic, prognostic, and predictive biomarker;Gene;2022-11

5. Association of HOTAIR rs1899663 G>T Polymorphism with Colorectal Cancer in the Turkish Population: A Case–Control Study;The Turkish Journal of Gastroenterology;2022-08-19